Baricitinib preserves beta cell function in new-onset type 1 diabetes
1. In this randomized controlled trial, baricitinib, a Janus kinase (JAK) inhibitor, preserved beta cell function and reduced insulin requirement ...
1. In this randomized controlled trial, baricitinib, a Janus kinase (JAK) inhibitor, preserved beta cell function and reduced insulin requirement ...
1. In this retrospective study, in patients with prolonged symptoms of coronavirus disease 2019 (COVID-19), cognitive deficits lasting a year ...
1. In this case-control study, cerebrospinal fluid (CSF) biomarkers of Alzheimer’s disease increased during the decline of cognitive function. 2. ...
1. In this randomized controlled trial, among patients with primary biliary cholangitis (PBC) who had had inadequate response to ursodeoxycholic ...
1. In this randomized controlled trial, primary biliary cholangitis (PBC) patients who received elafibranor had significantly improved serum markers of ...
1. In this retrospective cohort study, patients achieving surgical remission of Cushing’s disease (CD) had a higher incidence of autoimmune ...
1. In this randomized controlled trial, multiple sclerosis patients who received frexalimab had fewer new gadolinium-enhancing T1 lesions compared to ...
1. In this randomized controlled trial, the success rate of surgery was greater than that of needle fasciotomy and collagenase ...
1. In this cohort study, estimated glomerular filtration rate based on both creatinine and cystatin C (eGFRcr-cys ) was more strongly ...
1. In this randomized controlled trial, treatment with JNJ-77242113 improved psoriasis symptoms as compared to a placebo. 2. JNJ-77242113 showed ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.